15 drug(s) with this reaction
11,542 total reports
Sinusitis has been reported as an adverse reaction across 15 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 11,542 adverse event reports mention sinusitis in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with sinusitis, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have sinusitis listed in their FDA adverse event reports, sorted by report count:
In addition to sinusitis, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
15 drug(s) manufactured by Haleon Us Holdings Llc have sinusitis listed in their FDA adverse event reports: DICLOFENAC SODIUM, FLUTICASONE PROPIONATE, CALCIUM CARBONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, IBUPROFEN SODIUM, and others.
There are a combined 11,542 reports of sinusitis across 15 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.